Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Expert Review of Anti-Infective Therapy|November 6, 2018
Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adultsMartina Properzi, Paola Magro, Francesco Castelli, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 InfectionIsabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Le Infezioni in Medicina|January 10, 2013
Male breast cancer in an HIV-infected patient: a case reportAlessandra Calabresi, Filippo Castelnuovo, Alice Ferraresi, et al.
Pharmacological Research|May 21, 2020
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?Eugenia Quiros Roldan, Giorgio Biasiotto, Paola Magro, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. <i>Pharmaceuticals</i> 2021, <i>14</i>, 454Isabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Microorganisms|April 27, 2024
The Impact of Immune System Aging on Infectious DiseasesEugenia Quiros-Roldan, Alessandra Sottini, Pier Giorgio Natali, et al.
The International Journal of Risk & Safety in Medicine|October 3, 2022
Two cases of drug induced hypersensitivity to dolutegravir-rilpivirine fixed-dose combination: A case reportGiovanni Del Fabro, Palmiro Mileto, Francesco Castelli, et al.
Biomedical Journal|February 20, 2021
Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatmentPaola Magro, Isabella Zanella, Marta Pescarolo, et al.
Drug Design, Development and Therapy|December 18, 2025
Detailed in silico Evaluation of WNV Proteins: Dynamic and Thermodynamic Insights into Doravirine as a Potential Multitarget AgentAntonio Curcio, Carlo Torti, Eugenia Quiros-Roldan, et al.
Health Science Reports|April 21, 2025
Effects of Climate Change on the Immune System: A Narrative ReviewLuisa Imberti, Giorgio Tiecco, Jacopo Logiudice, et al.
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Expert Review of Anti-Infective Therapy|November 6, 2018
Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adultsMartina Properzi, Paola Magro, Francesco Castelli, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 InfectionIsabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Le Infezioni in Medicina|January 10, 2013
Male breast cancer in an HIV-infected patient: a case reportAlessandra Calabresi, Filippo Castelnuovo, Alice Ferraresi, et al.
Pharmacological Research|May 21, 2020
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?Eugenia Quiros Roldan, Giorgio Biasiotto, Paola Magro, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. <i>Pharmaceuticals</i> 2021, <i>14</i>, 454Isabella Zanella, Daniela Zizioli, Francesco Castelli, et al.
Microorganisms|April 27, 2024
The Impact of Immune System Aging on Infectious DiseasesEugenia Quiros-Roldan, Alessandra Sottini, Pier Giorgio Natali, et al.
The International Journal of Risk & Safety in Medicine|October 3, 2022
Two cases of drug induced hypersensitivity to dolutegravir-rilpivirine fixed-dose combination: A case reportGiovanni Del Fabro, Palmiro Mileto, Francesco Castelli, et al.
Biomedical Journal|February 20, 2021
Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatmentPaola Magro, Isabella Zanella, Marta Pescarolo, et al.
Drug Design, Development and Therapy|December 18, 2025
Detailed in silico Evaluation of WNV Proteins: Dynamic and Thermodynamic Insights into Doravirine as a Potential Multitarget AgentAntonio Curcio, Carlo Torti, Eugenia Quiros-Roldan, et al.
Health Science Reports|April 21, 2025
Effects of Climate Change on the Immune System: A Narrative ReviewLuisa Imberti, Giorgio Tiecco, Jacopo Logiudice, et al.
Pageof 21